|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2003-4-3
|
|
pubmed:abstractText |
The authors previously observed that antiangiogenic scheduling of photodynamic therapy (PDT) was effective in causing tumor regression through hemostasis. It would thus be expected that photosensitizer entrapped in polycation liposomes (PCLs) would be efficiently taken up in tumor-derived angiogenic vascular endothelial cells due to the strong electrostatic adhesion between the polycation and the plasma membrane, thus resulting in enhanced phototherapeutic efficacy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amines,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31,
http://linkedlifedata.com/resource/pubmed/chemical/Green Fluorescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/Luminescent Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Polyamines,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethyleneimine,
http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins,
http://linkedlifedata.com/resource/pubmed/chemical/benzoporphyrin D,
http://linkedlifedata.com/resource/pubmed/chemical/hexadecylamine,
http://linkedlifedata.com/resource/pubmed/chemical/polycations
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
97
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2027-34
|
|
pubmed:dateRevised |
2005-10-1
|
|
pubmed:meshHeading |
pubmed-meshheading:12673734-Air Sacs,
pubmed-meshheading:12673734-Amines,
pubmed-meshheading:12673734-Animals,
pubmed-meshheading:12673734-Antigens, CD31,
pubmed-meshheading:12673734-Apoptosis,
pubmed-meshheading:12673734-Endothelium, Vascular,
pubmed-meshheading:12673734-Fluorescent Antibody Technique,
pubmed-meshheading:12673734-Green Fluorescent Proteins,
pubmed-meshheading:12673734-In Situ Nick-End Labeling,
pubmed-meshheading:12673734-Liposomes,
pubmed-meshheading:12673734-Luminescent Proteins,
pubmed-meshheading:12673734-Male,
pubmed-meshheading:12673734-Mice,
pubmed-meshheading:12673734-Mice, Inbred BALB C,
pubmed-meshheading:12673734-Neovascularization, Pathologic,
pubmed-meshheading:12673734-Photochemotherapy,
pubmed-meshheading:12673734-Photosensitizing Agents,
pubmed-meshheading:12673734-Polyamines,
pubmed-meshheading:12673734-Polyethyleneimine,
pubmed-meshheading:12673734-Porphyrins,
pubmed-meshheading:12673734-Sarcoma, Experimental,
pubmed-meshheading:12673734-Skin Neoplasms
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
|
|
pubmed:affiliation |
Department of Medical Biochemistry and COE Program in the 21st Century, University of Shizuoka School of Pharmaceutical Sciences, Shizuoka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
